Multiple micronutrient supplements versus iron-folic acid supplements and maternal anemia outcomes: an iron dose analysis

Antenatal multiple micronutrient supplements (MMS) are more effective than iron and folic acid (IFA) supplements in reducing adverse pregnancy outcomes. Questions remain, however, about the ability of MMS to prevent anemia as effectively as IFA, especially at a lower dose of daily iron and in areas...

Full description

Bibliographic Details
Main Authors: Gomes, F, Agustina, R, Black, RE, Christian, P, Dewey, KG, Kraemer, K, Shankar, AH, Smith, ER, Thorne-Lyman, A, Tumilowicz, A, Bourassa, MW
Format: Journal article
Language:English
Published: Wiley 2022
_version_ 1797107128501010432
author Gomes, F
Agustina, R
Black, RE
Christian, P
Dewey, KG
Kraemer, K
Shankar, AH
Smith, ER
Thorne-Lyman, A
Tumilowicz, A
Bourassa, MW
author_facet Gomes, F
Agustina, R
Black, RE
Christian, P
Dewey, KG
Kraemer, K
Shankar, AH
Smith, ER
Thorne-Lyman, A
Tumilowicz, A
Bourassa, MW
author_sort Gomes, F
collection OXFORD
description Antenatal multiple micronutrient supplements (MMS) are more effective than iron and folic acid (IFA) supplements in reducing adverse pregnancy outcomes. Questions remain, however, about the ability of MMS to prevent anemia as effectively as IFA, especially at a lower dose of daily iron and in areas of high anemia prevalence. Analyzing data from 11 trials from a recent Cochrane review, we compared MMS to IFA, delivering either 30 or 60 mg of iron, in sustaining hemoglobin and preventing third trimester anemia and iron deficiency anemia (IDA), accounting for daily iron dose, total supplemental iron intake, and baseline prevalence of anemia. There were no differences between MMS and IFA in third trimester hemoglobin concentration or risks of anemia or IDA by iron dose or total supplemental iron consumed. MMS providing 30 mg of iron was comparable to IFA with 60 mg of iron: mean hemoglobin difference of -0.26 g/L (95% CI: -1.41 to 0.89), risk ratios of 0.99 (95% CI: 0.92-1.07) for anemia, and 1.31 (95% CI: 0.66-2.60) for IDA. Baseline prevalence of anemia did not explain heterogeneity in findings. Compared to IFA, MMS results in comparable hemoglobin concentration and protection against anemia during pregnancy, independently of iron dose.
first_indexed 2024-03-07T07:10:32Z
format Journal article
id oxford-uuid:41b415e3-66cf-4672-a3a6-208a4676acee
institution University of Oxford
language English
last_indexed 2024-03-07T07:10:32Z
publishDate 2022
publisher Wiley
record_format dspace
spelling oxford-uuid:41b415e3-66cf-4672-a3a6-208a4676acee2022-06-30T09:16:56ZMultiple micronutrient supplements versus iron-folic acid supplements and maternal anemia outcomes: an iron dose analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:41b415e3-66cf-4672-a3a6-208a4676aceeEnglishSymplectic ElementsWiley2022Gomes, FAgustina, RBlack, REChristian, PDewey, KGKraemer, KShankar, AHSmith, ERThorne-Lyman, ATumilowicz, ABourassa, MWAntenatal multiple micronutrient supplements (MMS) are more effective than iron and folic acid (IFA) supplements in reducing adverse pregnancy outcomes. Questions remain, however, about the ability of MMS to prevent anemia as effectively as IFA, especially at a lower dose of daily iron and in areas of high anemia prevalence. Analyzing data from 11 trials from a recent Cochrane review, we compared MMS to IFA, delivering either 30 or 60 mg of iron, in sustaining hemoglobin and preventing third trimester anemia and iron deficiency anemia (IDA), accounting for daily iron dose, total supplemental iron intake, and baseline prevalence of anemia. There were no differences between MMS and IFA in third trimester hemoglobin concentration or risks of anemia or IDA by iron dose or total supplemental iron consumed. MMS providing 30 mg of iron was comparable to IFA with 60 mg of iron: mean hemoglobin difference of -0.26 g/L (95% CI: -1.41 to 0.89), risk ratios of 0.99 (95% CI: 0.92-1.07) for anemia, and 1.31 (95% CI: 0.66-2.60) for IDA. Baseline prevalence of anemia did not explain heterogeneity in findings. Compared to IFA, MMS results in comparable hemoglobin concentration and protection against anemia during pregnancy, independently of iron dose.
spellingShingle Gomes, F
Agustina, R
Black, RE
Christian, P
Dewey, KG
Kraemer, K
Shankar, AH
Smith, ER
Thorne-Lyman, A
Tumilowicz, A
Bourassa, MW
Multiple micronutrient supplements versus iron-folic acid supplements and maternal anemia outcomes: an iron dose analysis
title Multiple micronutrient supplements versus iron-folic acid supplements and maternal anemia outcomes: an iron dose analysis
title_full Multiple micronutrient supplements versus iron-folic acid supplements and maternal anemia outcomes: an iron dose analysis
title_fullStr Multiple micronutrient supplements versus iron-folic acid supplements and maternal anemia outcomes: an iron dose analysis
title_full_unstemmed Multiple micronutrient supplements versus iron-folic acid supplements and maternal anemia outcomes: an iron dose analysis
title_short Multiple micronutrient supplements versus iron-folic acid supplements and maternal anemia outcomes: an iron dose analysis
title_sort multiple micronutrient supplements versus iron folic acid supplements and maternal anemia outcomes an iron dose analysis
work_keys_str_mv AT gomesf multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT agustinar multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT blackre multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT christianp multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT deweykg multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT kraemerk multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT shankarah multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT smither multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT thornelymana multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT tumilowicza multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis
AT bourassamw multiplemicronutrientsupplementsversusironfolicacidsupplementsandmaternalanemiaoutcomesanirondoseanalysis